The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125462861 12546286 1 I 20160630 20160711 20160711 EXP PHHY2016GR091298 NOVARTIS 0.00 F Y 0.00000 20160711 CN US GR

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125462861 12546286 1 PS AFINITOR EVEROLIMUS 1 Unknown U 22334
125462861 12546286 2 SS CAPECITABINE. CAPECITABINE 1 Unknown U 0
125462861 12546286 3 SS TAMOXIFEN TAMOXIFEN 1 Unknown U 0
125462861 12546286 4 SS EXEMESTANE. EXEMESTANE 1 Unknown U 0
125462861 12546286 5 SS CARBOPLATIN. CARBOPLATIN 1 Unknown U 0
125462861 12546286 6 SS GEMCITABINE HYDROCHLORIDE. GEMCITABINE HYDROCHLORIDE 1 Unknown U 0
125462861 12546286 7 SS PACLITAXEL. PACLITAXEL 1 Unknown U 0
125462861 12546286 8 SS NAVELBINE VINORELBINE TARTRATE 1 Unknown U 0
125462861 12546286 9 SS FASLODEX FULVESTRANT 1 Unknown U 0
125462861 12546286 10 SS ABRAXANE PACLITAXEL 1 Unknown U 0
125462861 12546286 11 SS ERIBULIN ERIBULIN 1 Unknown U 0
125462861 12546286 12 SS BEVACIZUMAB BEVACIZUMAB 1 Unknown U 0
125462861 12546286 13 SS LIPOSOMAL DOXORUBICIN HCL DOXORUBICIN HYDROCHLORIDE 1 Unknown U 0
125462861 12546286 14 SS DOCETAXEL. DOCETAXEL 1 Unknown U 0
125462861 12546286 15 SS EPIRUBICIN HCL EPIRUBICIN HYDROCHLORIDE 1 Unknown U 0
125462861 12546286 16 SS CYCLOPHOSPHAMIDE. CYCLOPHOSPHAMIDE 1 Unknown U 0
125462861 12546286 17 SS ANASTROZOLE. ANASTROZOLE 1 Unknown U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125462861 12546286 1 Breast cancer metastatic
125462861 12546286 2 Breast cancer metastatic
125462861 12546286 3 Breast cancer metastatic
125462861 12546286 4 Breast cancer metastatic
125462861 12546286 5 Breast cancer metastatic
125462861 12546286 6 Breast cancer metastatic
125462861 12546286 7 Breast cancer metastatic
125462861 12546286 8 Breast cancer metastatic
125462861 12546286 9 Breast cancer metastatic
125462861 12546286 10 Breast cancer metastatic
125462861 12546286 11 Breast cancer metastatic
125462861 12546286 12 Breast cancer metastatic
125462861 12546286 13 Breast cancer metastatic
125462861 12546286 14 Breast cancer metastatic
125462861 12546286 15 Breast cancer metastatic
125462861 12546286 16 Breast cancer metastatic
125462861 12546286 17 Breast cancer metastatic

Outcome of event

Event ID CASEID OUTC COD
125462861 12546286 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
125462861 12546286 Acute lymphocytic leukaemia
125462861 12546286 Metastases to chest wall
125462861 12546286 Second primary malignancy

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found